Gross <i>SDHB</i> deletions in patients with paraganglioma detected by multiplex PCR: A possible hot spot?
Alberto Cascón(Spanish National Cancer Research Centre), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Beatriz Martínez–Delgado(Centre for Biomedical Network Research on Rare Diseases), Fátima Mercadillo(Spanish National Cancer Research Centre), Sergio Ruiz‐Llorente(Consejo Superior de Investigaciones Científicas), José Ángel Díaz(Hospital Clínico San Carlos), Alberto B. Díez(Hospital El Bierzo), Adela Rovira(Hospital Universitario Fundación Jiménez Díaz), Cristina Montero‐Conde(Spanish National Cancer Research Centre), Rocío Letón, Manuel Delgado(Hospital El Bierzo), Cristina Rodríguez‐Antona(Instituto de Salud Carlos III)
Cited by 78
Related Papers
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
|Nature Genetics|2011|528
Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension
|Journal of Hypertension|2020|406
Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas
|Human Molecular Genetics|2013|394
<i>MAX</i> Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma
|Clinical Cancer Research|2012|330
An Update on the Genetics of Paraganglioma, Pheochromocytoma, and Associated Hereditary Syndromes
|Hormone and Metabolic Research|2012|287